Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review

Regenerative Therapy - Tập 11 - Trang 56-64 - 2019
Peter A. Everts1, Gerard A. Malanga2,3, Rowan V. Paul4,5,6, Joshua B. Rothenberg7,8, Natalie Stephens9, Kenneth R. Mautner10,11
1Gulf Coast Biologics, Scientific and Research Department, Fort Myers, FL, USA
2New Jersey Regenerative Institute LLC, Cedar Knolls, NJ, USA
3Department of Physical Medicine and Rehabilitation, Rutgers University, New Jersey Medical School, Newark, NJ, USA
4California Pacific Orthopedics, San Francisco, CA, USA
5California Pacific Medical Center, San Francisco, CA USA
6Dartmouth Geisel School of Medicine, Hanover, NH, USA
7Boca Raton Regional Hospital, Regenerative Medicine and Orthopedics Biologic Department, Boca Raton, FL, USA
8BocaCare Orthopedics, Boca Raton, FL, USA
9Biosciences Research Associates, Cambridge, MA, USA
10Emory University, Department of Physical Medicine & Rehabilitation, Atlanta GA, USA
11Emory University, Department of Orthopedics, Atlanta GA, USA

Tài liệu tham khảo

Yelin, 2016, The burden of musculoskeletal diseases in the United States, Semin Arthritis Rheum, 10.1016/j.semarthrit.2016.07.013 Andia, 2015, Platelet-rich Plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes, Clin Orthop Relat Res, 473, 1624, 10.1007/s11999-015-4179-z Sugaya, 2003, Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases, Int Rev Cytol, 228, 1, 10.1016/S0074-7696(03)28001-3 Malanga, 2015, Regenerative treatment for orthopedic conditions, PM R, 10.1016/j.pmrj.2015.01.016 Sanchez, 2017, Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair, Neural Regen Res, 12, 47, 10.4103/1673-5374.198973 Senzel, 2009, The platelet proteome, Curr Opin Hematol, 16, 329, 10.1097/MOH.0b013e32832e9dc6 Everts, 2006, Platelet rich plasma and platelet gel: a review, J Extra Corpor Technol, 38, 174, 10.1051/ject/200638174 Kovtun, 2016, The crucial role of neutrophil granulocytes in bone fracture healing, Eur Cell Mater, 32, 152, 10.22203/eCM.v032a10 Fitzpatrick, 2016, The effectiveness of platelet-rich plasma in the treatment of tendinopathy. a meta-analysis of randomized controlled clinical trials, Am J Sports Med, 10.1177/0363546516669322 Jorgensen, 2011, Mesenchymal stem cells in osteoarticular diseases, Regen Med, 6, 44, 10.2217/rme.11.80 Oh, 2015, The perivascular niche and self-renewal of stem cells, Front Physiol, 10.3389/fphys.2015.00367 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Otero-Vinas, 2016, Mesenchymal stem cells in chronic wounds: the spectrum from basic to advanced therapy, Adv Wound Care (New Rochelle), 5, 149, 10.1089/wound.2015.0627 Mithoefer, 2009, Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis, Am J Sports Med, 37, 2053, 10.1177/0363546508328414 da Silva Meirelles, 2009, Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev, 20, 419, 10.1016/j.cytogfr.2009.10.002 Bashir, 2014, Mesenchymal stem cell therapies in the treatment of musculoskeletal diseases, PMR, 6, 61, 10.1016/j.pmrj.2013.05.007 Das, 2015, Monocyte and macrophage plasticity in tissue repair and regeneration, Am J Pathol, 185, 2596, 10.1016/j.ajpath.2015.06.001 Orozco, 2014, Treatment of knee osteoarthritis with autologous mesenchymal stem cells: Two-year follow-up results, Transplantation, 97, e66, 10.1097/TP.0000000000000167 Hernigou, 2014, Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study, Int Orthop, 38, 1811, 10.1007/s00264-014-2391-1 Mautner, 2015, A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature, PM R, 10.1016/j.pmrj.2015.02.005 Murray, 2018, Reporting standards in clinical studies evaluating bone marrow aspirate concentrate: a systematic review, Arthroscopy, 34, 1366, 10.1016/j.arthro.2017.11.036 Magalon, 2016, DEPA classification: a proposal for standardizing PRP use and a retrospective application of available devices, BMJ Open Sport Exerc Med, 2, 1, 10.1136/bmjsem-2015-000060 Schaer, 2013, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, 121, 1276, 10.1182/blood-2012-11-451229 Klatt, 2018, Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis, J Clin Invest, 128, 3906, 10.1172/JCI92077 Karsten, 2018, Red blood cells: The primary reservoir of macrophage migration inhibitory factor in whole blood, Cytokine, 102, 34, 10.1016/j.cyto.2017.12.005 Mazzucco, 2009, Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure, Vox Sang, 97, 110, 10.1111/j.1423-0410.2009.01188.x Everts, 2006, Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation, Transfus Med, 16, 363, 10.1111/j.1365-3148.2006.00708.x Degen, 2017, Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition, HSS J, 13, 75, 10.1007/s11420-016-9519-3 Giusti, 2009, Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells, Transfusion, 49, 771, 10.1111/j.1537-2995.2008.02033.x Cavallo, 2014, Comparison of platelet rich plasma formulations for cartilage healing: an in vitro study, J Bone Joint Surg Am, 96, 423, 10.2106/JBJS.M.00726 Dragoo, 2012, Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons, Am J Sports Med, 40, 1274, 10.1177/0363546512442334 DeLong, 2012, Platelet-rich plasma: The PAW classification system, Arthroscopy, 28, 998, 10.1016/j.arthro.2012.04.148 Dohan Ehrenfest, 2014, Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives, Muscles Ligaments Tendons J, 4, 3, 10.32098/mltj.01.2014.02 Muschler, 2001, Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors, J Orthop Res, 19, 117, 10.1016/S0736-0266(00)00010-3 Pontikoglou, 2011, Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation, Stem Cell Rev, 7, 569, 10.1007/s12015-011-9228-8 Chamberlain, 2007, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing, J. Stem Cell, 2739, 2739, 10.1634/stemcells.2007-0197 Moatsche, 2017, Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates A review of the current status, Acta Orthop, 88, 670, 10.1080/17453674.2017.1368899 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Fong, 2011, Stem cell homing in musculoskeletal injury, Biomaterials, 32, 395, 10.1016/j.biomaterials.2010.08.101 Imam, 2017, A systematic review of the clinical applications and complications of bone marrow aspirate concentrate in management of bone defects and nonunions, SICOT J Braun, 2014, The effect of platelet rich plasma formulations and blood products on human synoviocytes: Implications for intra-articular injury and therapy, Am J Sports Med, 42, 1204, 10.1177/0363546514525593 Hooiveld, 2003, Short term exposure of cartilage to blood results in apoptosis, Am J Pathol, 162, 943, 10.1016/S0002-9440(10)63889-8 Tajima, 2017, Hemoglobin stimulates the expression of ADAMTS-5 and ADAMTS-9 by synovial cells: a possible cause of articular cartilage damage after intra-articular hemorrhage, BMC Muskuloskelet Disord, 18, 449, 10.1186/s12891-017-1815-7 Dawson, 2013, Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration, Cytotherapy, 15, 242, 10.1016/j.jcyt.2012.09.004 Chahla, 2017, A call for standardization in platelet-rich plasma preparation protocols and composition reporting. A systematic review of the clinical orthopaedic literature, J Bone Joint Surg Am, 99, 1769, 10.2106/JBJS.16.01374 Finch, 1982, Erythropoiesis, erythropoietin, and iron, Blood, 60, 1241, 10.1182/blood.V60.6.1241.1241 Mohandas, 2008, Red cell membrane: past, present, and future, Blood, 112, 3939, 10.1182/blood-2008-07-161166 Park, 2010, Measurement of red blood cell mechanics during morphological changes, Proc Natl Acad Sci, 107, 6731, 10.1073/pnas.0909533107 Lang, 2005, Mechanisms of suicidal erythrocyte death, Cell Physiol Biochem, 15, 195, 10.1159/000086406 Ghashghaeinia, 2012, The impact of erythrocyte age on eryptosis, British J Haemat, 157, 606, 10.1111/j.1365-2141.2012.09100.x Frei, 2008, Vascular dysfunction in a murine model of severe hemolysis, Blood, 112, 398, 10.1182/blood-2007-12-126714 Gozzelino, 2010, Mechanisms of cell protection by heme oxygenase-1, Annu Rev Pharmacol Toxicol, 50, 323, 10.1146/annurev.pharmtox.010909.105600 Jones, 1995, A relationship between Reynolds stresses and viscous dissipation: implications to red cell damage, Ann Biomed Eng, 23, 21, 10.1007/BF02368297 Meyer, 2010, Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function, J Am Coll Cardiol, 55, 454, 10.1016/j.jacc.2009.07.068 Figueiredo, 2007, Characterization of heme as activator of toll-like receptor 4, J Biol Chem, 282, 20221, 10.1074/jbc.M610737200 Kumar, 2005, Free heme toxicity and its detoxification systems in human, Toxicol Lett, 157, 175, 10.1016/j.toxlet.2005.03.004 Vinchi, 2013, Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis, Oxid Med Cell Long, 10.1155/2013/396527 Jeney, 2002, Pro-oxidant and cytotoxic effects of circulating heme, Blood, 100, 879, 10.1182/blood.V100.3.879 Nagy, 2010, Red cells, hemoglobin, heme, iron, and atherogenesis, Arterioscler Thromb Vasc Biol, 30, 1347, 10.1161/ATVBAHA.110.206433 Smith, 2015, Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders, Front Physiol, 10.3389/fphys.2015.00187 Seixas, 2009, Heme oxygenase-1 affords protection against noncerebral forms of severemalaria, Proc Natl Acad Sci USA, 106, 15837, 10.1073/pnas.0903419106 Ogawa, 2001, Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1, EMBO J, 20, 283543, 10.1093/emboj/20.11.2835 Alayash, 2004, Oxygen therapeutics: can we tame haemoglobin?, Nat Rev Drug Discov, 3, 152, 10.1038/nrd1307 Rother, 2005, The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin, JAMA, 293, 1653, 10.1001/jama.293.13.1653 Repsold, 2018, Eryptosis: An erythrocyte’s suicidal type of cell death, BioMed Res Int, 10.1155/2018/9405617 Berg, 2015, Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis, Cell Death Differ, 8, 1197, 10.1038/sj.cdd.4400905 Esmon, 2005, The interactions between inflammation and coagulation, Br. J Haematol, 131, 417, 10.1111/j.1365-2141.2005.05753.x Betal, 2008, Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin binding domain, Trans Res, 152, 165, 10.1016/j.trsl.2008.07.007 Baugh, 2002, Macrophage migration inhibitory factor, Critical Care Med, 30, S27, 10.1097/00003246-200201001-00004 Lehmann, 2005, Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes, Free Radic Biol Med, 38, 1170, 10.1016/j.freeradbiomed.2004.12.029 Jensen, 2001, Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count, Eur J Haematol, 66, 143, 10.1034/j.1600-0609.2001.00359.x Calandra, 1995, MIF as a glucocorticoid-induced modulator of cytokine production, Nature, 377, 68, 10.1038/377068a0 Pohl, 2016, MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real-life cohort, Resuscitation, 100, 32, 10.1016/j.resuscitation.2015.12.015 Zhang, 2016, Synovial fluid macrophage migration inhibitory factor levels correlate with the severity of self-reported pain in knee osteoarthritis patients, Med Sci Monit, 22, 2182, 10.12659/MSM.895704 Liu, 2012, Association of MIF serum and synovial fluid with severity of knee osteoarthritis, Clin Biochem, 45, 737, 10.1016/j.clinbiochem.2012.03.012 Michiels, 2003, Endothelial cell functions, J Cell Physiol, 196, 430, 10.1002/jcp.10333 Maitz, 2015, Applications of synthetic polymers in clinical medicine, Biosurf Biotribology, 1, 161, 10.1016/j.bsbt.2015.08.002 Nakagawa-Tosa, 1995, Stimulation of haptoglobin synthesis by interleukin-6 and tumor necrosis factor, but not by interleukin-1, in bovine primary cultured hepatocytes, J Vet Med Sci, 57, 219, 10.1292/jvms.57.219 Harrison, 2011, Erythrocytes inhibit ligament fibroblast proliferation in a collagen scaffold, J Orthop Res, 29, 1361, 10.1002/jor.21321 Xiong, 2012, Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74, PLoS One, 10.1371/annotation/a5edef40-e46d-4810-9008-dbda429ccc2c Alves, 2018, A review of platelet-rich plasma: history, biology, mechanisms of action, and classification, Skin Appendage Disord, 4, 18, 10.1159/000477353 Grisendi, 2010, GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion, Cytotherapy, 12, 466, 10.3109/14653241003649510